CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.035
NA - Nord America 1.995
AS - Asia 1.134
AF - Africa 13
SA - Sud America 12
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.984
CN - Cina 741
GB - Regno Unito 577
SG - Singapore 285
IT - Italia 269
RU - Federazione Russa 229
SE - Svezia 211
DE - Germania 203
IE - Irlanda 185
FR - Francia 175
FI - Finlandia 82
JP - Giappone 38
UA - Ucraina 31
VN - Vietnam 21
AT - Austria 17
BE - Belgio 16
TR - Turchia 11
ES - Italia 10
CA - Canada 9
TG - Togo 9
KR - Corea 8
ID - Indonesia 7
IR - Iran 7
NL - Olanda 7
AU - Australia 4
CL - Cile 4
RO - Romania 4
AR - Argentina 3
BR - Brasile 3
CZ - Repubblica Ceca 3
IN - India 3
ZA - Sudafrica 3
DK - Danimarca 2
GR - Grecia 2
HK - Hong Kong 2
KG - Kirghizistan 2
MX - Messico 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
Totale 5.196
Salva come PNG Salva come JPEG
Città #
Southend 555
Chandler 478
Singapore 251
Dublin 185
Jacksonville 136
Redmond 134
Ashburn 126
Beijing 122
Ann Arbor 94
Lawrence 70
New York 70
Princeton 70
Wilmington 68
Bologna 67
Woodbridge 66
Shenyang 54
Helsinki 53
Jinan 49
Nanjing 44
Verona 39
Tokyo 35
Hebei 34
Houston 30
Sindelfingen 30
Tianjin 29
Milan 26
Haikou 25
Ningbo 25
Zhengzhou 24
Changsha 23
Hangzhou 22
Taiyuan 20
Vienna 17
Brussels 16
Guangzhou 16
Washington 16
Nanchang 15
Seattle 15
Norwalk 14
Redwood City 14
Jiaxing 13
Taizhou 13
Moscow 12
Venice 12
Dong Ket 11
Fuzhou 11
Santa Clara 11
Dallas 10
Fairfield 10
Lomé 9
San Francisco 8
Chicago 7
Denver 7
Jakarta 7
Kent 7
Seoul 7
Boardman 6
Cagliari 6
Düsseldorf 6
Falkenstein 6
Falls Church 6
Los Angeles 6
Munich 6
Dearborn 5
Lanzhou 5
Nürnberg 5
Shanghai 5
Bari 4
Cambridge 4
Dongguan 4
Lappeenranta 4
Miami 4
Rome 4
San Mateo 4
Toronto 4
Turin 4
Ardabil 3
Barcelona 3
Bilbao 3
Brno 3
Buenos Aires 3
Detroit 3
Leawood 3
Palermo 3
Amsterdam 2
Augusta 2
Benevento 2
Bishkek 2
Bratislava 2
Brescia 2
Böblingen 2
Cascina 2
Chiampo 2
Clearwater 2
Esslingen am Neckar 2
Frankfurt am Main 2
Giavera del Montello 2
Giugliano in Campania 2
Gunzenhausen 2
Kemerovo 2
Totale 3.486
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 174
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 150
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 133
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 123
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 116
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 113
Osteoporosis treatment: why ibandronic acid? 107
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 107
Anti-CCP antibodies and bone 104
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 103
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 98
Bone involvement and osteoporosis in mastocytosis. 96
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 91
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 91
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 90
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 88
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 87
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 87
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 86
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 85
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 84
Rheumatoid arthritis, γδ T cells and bisphosphonates 83
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 83
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 82
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 80
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 78
Bone Disease in Mastocytosis 77
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 77
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 76
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 76
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 74
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 73
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 73
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 70
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 70
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 70
Association between environmental air pollution and rheumatoid arthritis flares 70
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 64
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 63
Osteoporosis in Rheumatic Diseases 63
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 62
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 61
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 58
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 57
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 57
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 56
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 55
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 55
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 54
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 52
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 51
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 51
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 50
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 50
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 50
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 50
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 49
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 49
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 48
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 44
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 43
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 42
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 42
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 38
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 31
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 30
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 29
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 29
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 29
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 29
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 28
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 28
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 27
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 26
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 24
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 22
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 20
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 16
Changes in bone turnover markers and bone modulators during abatacept treatment 15
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 14
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 2
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 1
Totale 5.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.418
article - articoli 22.157
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 261
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020233 0 0 0 0 0 0 57 18 40 29 33 56
2020/2021724 101 118 24 130 102 53 28 8 44 3 68 45
2021/2022602 56 166 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/2025688 82 103 77 285 90 50 1 0 0 0 0 0
Totale 5.372